In addition to non-pharmacological measures (diet, physical activity, lifestyle behavior, etc.), the therapy options for CKD and fibrosis include angiotensin-converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs), etc., and dialysis for severe cases (Fried et al., 2021). Here, ACE is linked to chronic kidney disease.